title: Successful rifampin desensitization in a pediatric patient with latent tuberculosis.
authors.affiliation: Division of Immunology, Boston Children's Hospital, Boston, MA, USA. stephanie.logsdon@childrens.harvard.edu.
authors.forename: Stephanie
authors.initials: S
authors.lastname: Logsdon
authors.forename: Lynn
authors.initials: L
authors.lastname: Ramirez-Avila
authors.forename: Mariana
authors.initials: M
authors.lastname: Castells
authors.forename: Anahita
authors.initials: A
authors.lastname: Dioun
mesh_terms: D002648:Child; D002985:Clinical Protocols; D000075202:Contraindications; D003888:Desensitization, Immunologic / Q000379:methods*; D004155:Diphenhydramine / Q000008:administration & dosage; D054796:Drug Dosage Calculations; D004342:Drug Hypersensitivity / Q000209:etiology* / Q000628:therapy*; D005076:Exanthema / Q000209:etiology* / Q000628:therapy*; D005955:Glucosephosphate Dehydrogenase Deficiency / Q000150:complications; D006801:Humans; D007108:Immune Tolerance; D007538:Isoniazid; D055985:Latent Tuberculosis / Q000150:complications / Q000188:drug therapy*; D008297:Male; D017828:Rifabutin / Q000627:therapeutic use; D012293:Rifampin / Q000009:adverse effects*
chemical_list: D017828:Rifabutin; D004155:Diphenhydramine; D007538:Isoniazid; D012293:Rifampin